Several adaptor proteins promote intracellular localisation of the transporter MRP4/ABCC4 in platelets and haematopoietic cells

Summary

The multidrug resistance protein 4 (MRP4/ABCC4) has been identified as an important transporter for signalling molecules including cyclic nucleotides and several lipid mediators in platelets and may thus represent a novel target to interfere with platelet function. Besides its localisation in the plasma membrane, MRP4 has been also detected in the membrane of dense granules in resting platelets. In polarised cells it is localised at the basolateral or apical plasma membrane. To date, the mechanism of MRP4 trafficking has not been elucidated; protein interactions may regulate both the localisation and function of this transporter. We approached this issue by searching for interacting proteins by in vitro binding assays, followed by immunoblotting and mass spectrometry, and by visualising their co-localisation in platelets and haematopoietic cells. We identified the PDZ domain containing scaffold proteins ezrin-binding protein 50 (EBP50/NHERF1), postsynaptic density protein 95 (PSD95), and sorting nexin 27 (SNX27), but also the adaptor protein complex 3 subunit β3A (AP3B1) and the heat shock protein HSP90 as putative interaction partners of MRP4. The knockdown of SNX27, PSD95, and AP3B1 by siRNA in megakaryoblastic leuk aemia cells led to a redistribution of MRP4 from intracellular structures to the plasma membrane. Inhibition of HSP90 led to a diminished expression and retention of MRP4 in the endoplasmic reticulum. These results indicate that MRP4 localisation and function are regulated by multiple protein interactions. Changes in the adaptor proteins can hence lead to altered localisation and function of the transporter.

Supplementary Material to this article is available at www.thrombosis-online.com.

Keywords

Protein trafficking - PDZ domain - AP3B1 - HSP90 - delta-storage pool deficiencies

^* Present address: University Medicine Göttingen, Göttingen, Germany.

• References

• 1 Ritter CA, Jedlitschky G, Meyer zu Schwabedissen H. et al. Cellular export of drugs and signalling molecules by the ATP-binding cassette transporters MRP4 (ABCC4) and MRP5 (ABCC5). Drug Metab Rev 2005; 37: 253-278.
• 2 Jedlitschky G, Greinacher A, Kroemer HK. Transporters in human platelets: physiologic function and impact for pharmacotherapy. Blood 2012; 119: 3394-3402.
• 3 Sassi Y, Lipskaia L, Vandecasteele G. et al. Multidrug resistance-associated protein 4 regulates cAMP-dependent signalling pathways and controls human and rat SMC proliferation. J Clin Invest 2008; 118: 2747-2757.
• 4 Coepsel S, Garcia C, Diez F. et al. Multidrug resistance protein 4 (MRP4/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation. J Biol Chem 2011; 286: 6979-6988.
• 5 Jedlitschky G, Tirschmann K, Lubenow LE. et al. The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage. Blood 2004; 104: 3603-3610.
• 6 Rius M, Hummel-Eisenbeiss J, Keppler DJ. ATP-dependent transport of leukotrienes B4 and C4 by the multidrug resistance protein ABCC4 (MRP4). Pharmacol Exp Ther 2008; 324: 86-94.
• 7 Jedlitschky G, Cattaneo M, Lubenow LE. et al. Role of MRP4 (ABCC4) in platelet adenine nucleotide-storage: evidence from patients with delta-storage pool deficiencies. Am J Pathol 2010; 176: 1097-1103.
• 8 Niessen J, Jedlitschky G, Grube M. et al. Expression of ABC-type transport proteins in human platelets. Pharmacogenet Genomics 2010; 20: 396-400.
• 9 Mattiello T, Guerriero R, Lotti LV. et al. Aspirin extrusion from human platelets through multidrug resistance protein-4-mediated transport evidence of a reduced drug action in patients after coronary artery bypass grafting. J Am Coll Cardiol 2011; 58: 752-761.
• 10 Borgognone A, Pulcinelli FM. Reduction of cAMP and cGMP inhibitory effects in human platelets by MRP4-mediated transport. Thromb Haemost 2012; 108: 955-962.
• 11 Ulrych T, Böhm A, Polzin A. et al. Release of sphingosine-1-phosphate from human platelets is dependent on thromboxane formation. J Thromb Haemost 2011; 09: 790-798.
• 12 Decouture B, Dreano E, Belleville-Rolland T. et al. Impaired platelet activation and cAMP homeostasis in MRP4-deficient mice. Blood 2015; 126: 1823-1830.
• 13 Cheepala SB, Pitre A, Fukuda Y. et al. The ABCC4 membrane transporter modulates platelet aggregation. Blood 2015; 126: 2307-2319.
• 14 Lien LM, Chen ZC, Chung CL. et al. Multidrug resistance protein 4 (MRP4/ABCC4) regulates thrombus formation in vitro and in vivo. Eur J Pharmacol 2014; 737: 159-167.
• 15 Cattaneo M. Inherited, platelet-based bleeding disorders. J Thromb Haemost 2003; 12: 1628-1636.
• 16 Hermansky F, Pudlak P. Albinism associated with hemorrhagic diathesis and unusual pigmented reticular cells in the bone marrow. Blood 1959; 14: 162-169.
• 17 Hoque MT, Cole SP. Down-regulation of Na+/H+ exchanger regulatory factor 1 increases expression and function of multidrug resistance protein 4. Cancer Res 2008; 68: 4802-4809.
• 18 Park J, Kwak JO, Riederer B. et al. Na⁺/H⁺ exchanger regulatory factor 3 is critical for multidrug resistance protein 4-mediated drug efflux in the kidney. J Am Soc Nephrol 2014; 25: 726-736.
• 19 Hayashi H, Naoi S, Nakagawa T. et al. Sorting nexin 27 interacts with multidrug resistance-associated protein 4 (MRP4) and mediates internalisation of MRP4. J Biol Chem 2012; 287: 15054-15065.
• 20 Dell’Angelica EC. AP-3-dependent trafficking and disease: the first decade. Curr Opin Cell Biol 2009; 21: 552-559.
• 21 Jung J, Bohn G, Allroth A. et al. Identification of a homozygous deletion in the AP3B1 gene causing Hermansky-Pudlak syndrome, type 2. Blood 2006; 108: 362-369.
• 22 Oevermann L, Scheitz J, Starke K. et al. Haematopoietic stem cell differentiation affects expression and function of MRP4 (ABCC4), a transport protein for signalling molecules and drugs. Int J Cancer 2009; 124: 2303-2311.
• 23 Hermann A, Rauch BH, Braun M. et al. Platelet CD40 ligand (CD40L) - subcellular localisation, regulation of expression, and inhibition by clopidogrel. Platelets 2001; 12: 74-82.
• 24 Stannek L, Thiele MJ, Ischebeck T. et al. Evidence for synergistic control of glutamate biosynthesis by glutamate dehydrogenases and glutamate in Bacillus subtilis. Environ Microbiol 2015; 17: 3379-3390.
• 25 Rius M, Nies AT, Hummel-Eisenbeiss J. et al. Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane. Hepatology 2003; 38: 374-384.
• 26 Köck K, Koenen A, Giese B. et al. Rapid modulation of the organic anion transporting polypeptide 2B1 (OATP2B1, SLCO2B1) function by protein kinase C-mediated internalisation. J Biol Chem 2010; 285: 11336-11347.
• 27 Taldone Tl, Sun W, Chiosis G. Discovery and development of heat shock protein 90 inhibitors. Bioorg Med Chem 2009; 17: 2225-2235.
• 28 Sugiura Tl, Shimizu T, Kijima A. et al. PDZ adaptors: their regulation of epithelial transporters and involvement in human diseases. J Pharm Sci 2011; 100: 3620-3635.
• 29 Lee K, Klein-Szanto AJ, Kruh GD. Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells. J Natl Cancer Inst 2000; 92: 1934-1940.
• 30 van Aubel RA, Smeets PH, Peters JG. et al. The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP. J Am Soc Nephrol 2002; 13: 595-603.
• 31 Niessen J, Jedlitschky G, Grube M. et al. Subfractionation and purification of intracellular granule-structures of human platelets: an improved method based on magnetic sorting. J Immunol Methods 2007; 328: 89-96.
• 32 Short DB, Trotter KW, Reczek DJ. et al. An apical pdz protein anchors the cystic fibrosis transmembrane conductance regulator to the cytoskeleton. J Biol Chem 1998; 273: 19797-19801.
• 33 Swiatecka-Urban A, Duhaime M, Coutermarsh B. et al. Pdz domain interaction controls the endocytic recycling of the cystic fibrosis transmembrane conductance regulator. J Biol Chem 2002; 277: 40099-40105.
• 34 Fanning AS, Anderson JM. Protein modules as organizers of membrane structure. Curr Opin Cell Biol 1999; 11: 432-439.
• 35 Li C, Krishnamurthy PC, Penmatsa H. et al. Spatiotemporal coupling of cAMP transporter to CFTR chloride channel function in the gut epithelia. Cell 2007; 131: 940-951.
• 36 Moon C, Zhang W, Ren A. et al. Compartmentalized accumulation of cAMP near complexes of multidrug resistance protein 4 (MRP4) and cystic fibrosis transmembrane conductance regulator (CFTR) contributes to drug-induced diarrhea. J Biol Chem 2015; 290: 11246-11257.
• 37 de Bartolomeis A, Tomasetti C. Calcium-dependent networks in dopamine-glutamate interaction: the role of postsynaptic scaffolding proteins. Mol Neurobiol 2012; 46: 275-296.
• 38 Reed GL, Fitzgerald ML, Polgar J. Molecular mechanisms of platelet exocytosis: insights into the “secrete” life of thrombocytes. Blood 2000; 96: 3334-3342.
• 39 Ambrosio AL, Boyle JA, Di Pietro SM. Mechanism of platelet dense granule biogenesis: study of cargo transport and function of Rab32 and Rab38 in a model system. Blood 2012; 120: 4072-4081.
• 40 Khurana N, Bhattacharyya S. Hsp90, the concertmaster: tuning transcription. Front Oncol 2015; 05: 100
• 41 Suttitanamongkol S, Gear AR, Polanowska-Grabowska R. Geldanamycin disrupts platelet-membrane structure, leading to membrane permeabilisation and inhibition of platelet aggregation. Biochem J 2000; 345: 307-314.
• 42 Lalo U, Jones S, Roberts JA, Mahaut-Smith MP, Evans RJ. Heat shock protein 90 inhibitors reduce trafficking of ATP-gated P2×1 receptors and human platelet responsiveness. J Biol Chem 2012; 287: 32747-32754.